Stock 4530 HISAMITSU PHARMACEUTICAL CO., INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Hisamitsu Pharmaceutical Co., Inc.

Equities

4530

JP3784600003

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-25 am EDT 		5-day change 1st Jan Change
3,710 JPY -1.01% Intraday chart for Hisamitsu Pharmaceutical Co., Inc. -0.40% -13.94%
Apr. 11 Hisamitsu Pharmaceutical Attributable Profit Up 19% in Fiscal 2024 MT
Jan. 11 Hisamitsu Pharmaceutical Co., Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending February 29, 2024 CI

Business Summary

Hisamitsu Pharmaceutical Co Inc is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the manufacture, sale and supply of pharmaceuticals and related products, and the operation of over-the-counter drug (OTC) business. It is also engaged in the manufacture and sale of drugs in the United States, Brazil, Vietnam, and Indonesia, the development work in Europe, the drug marketing and sales in China and Hong Kong. It is also engaged in the urban cable television broadcasting business, Internet connection service business, non-life insurance agency business, advertising agency business and the purchase, manufacture and sale of packing materials.

Number of employees: 2,769

Sales per Business

JPY in Million2022Weight2023Weight Delta
Pharmaceutical
97.6 %
117,291 97.6 % 125,202 97.6 % +6.74%
Others
2.4 %
2,901 2.4 % 3,127 2.4 % +7.79%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
58.2 %
78,729 65.5 % 74,637 58.2 % -5.20%
United States
22.0 %
22,105 18.4 % 28,295 22.0 % +28.00%
Others
19.8 %
19,358 16.1 % 25,397 19.8 % +31.20%

Managers

Managers TitleAgeSince
Shinichiro Takao DFI
 Director of Finance/CFO 69 78-03-31
Kazuhide Nakatomi PSD
 President 51 99-03-31
Hirotaka Nakatomi CHM
 Chairman 87 66-01-31
Takaaki Terahara CTO
 Chief Tech/Sci/R&D Officer - -
Nobuo Tsutsumi CMP
 Compliance Officer 60 88-03-31
Shinichi Murayama BRD
 Director/Board Member 56 91-02-28
Naruhito Higo BRD
 Director/Board Member 61 85-03-31
Kyu Saito BRD
 Director/Board Member 60 87-03-31
Toshiaki Tsuruda BRD
 Director/Board Member 68 78-03-31
Kousuke Sugiyama BRD
 Director/Board Member 72 77-03-31

Members of the board

Members of the board TitleAgeSince
Hirotaka Nakatomi CHM
 Chairman 87 66-01-31
Kazuhide Nakatomi PSD
 President 51 99-03-31
Shinichiro Takao DFI
 Director of Finance/CFO 69 78-03-31
Tetsuo Akiyama BRD
 Director/Board Member 72 74-03-31
Isao Ichikawa BRD
 Director/Board Member 96 04-04-30
Toshiaki Tsuruda BRD
 Director/Board Member 68 78-03-31
Nobuo Tsutsumi CMP
 Compliance Officer 60 88-03-31
Naruhito Higo BRD
 Director/Board Member 61 85-03-31
Shinichi Murayama BRD
 Director/Board Member 56 91-02-28
Teijiro Furukawa BRD
 Director/Board Member 89 15-04-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 85,164,895 52,133,932 ( 61.22 %) 9,421,781 ( 11.06 %) 61.22 %

Shareholders

NameEquities%Valuation
HISAMITSU PHARMACEUTICAL CO., INC.
11.03 %
9,392,152 11.03 % 247 M ¥
Nishi Nippon City Bank Pension Fund
5.131 %
4,370,000 5.131 % 115 M ¥
Invesco Asset Management (Japan) Ltd.
4.949 %
4,215,200 4.949 % 111 M ¥
MUFG Bank Pension Fund
4.866 %
4,143,800 4.866 % 109 M ¥
Nippon Life Insurance Co.
4.591 %
3,910,000 4.591 % 103 M ¥
FUKUOKA FINANCIAL GROUP, INC.
3.958 %
3,371,000 3.958 % 88 M ¥
Hisamitsu Pharmaceutical Business Association
3.045 %
2,593,000 3.045 % 68 M ¥
THE BANK OF SAGA LTD.
2.766 %
2,356,000 2.766 % 62 M ¥
Sumitomo Mitsui Banking Pension Fund
2.424 %
2,064,000 2.424 % 54 M ¥
TKY KK
2.161 %
1,840,000 2.161 % 48 M ¥

Holdings

NameEquities%Valuation
HISAMITSU PHARMACEUTICAL CO., INC.
11.03%
 9,392,152 11.03% 246,556,012 $
TOPPAN INC.
0.53%
 1,757,720 0.53% 45,050,680 $
SUMITOMO REALTY & DEVELOPMENT CO., LTD.
0.24%
 1,151,000 0.24% 44,086,995 $
ONO PHARMACEUTICAL CO., LTD.
0.32%
 1,583,500 0.32% 25,681,060 $
SHIMANO INC.
0.17%
 154,400 0.17% 23,311,243 $
NISSIN FOODS HOLDINGS CO.,LTD.
0.23%
 716,699 0.23% 19,889,229 $
SEIREN CO.,LTD.
1.69%
 1,090,000 1.69% 19,863,353 $
YAKULT HONSHA CO.,LTD.
0.26%
 902,200 0.26% 18,593,025 $
OSAKA SODA CO., LTD.
0.98%
 261,000 0.98% 16,659,024 $
MIURA CO., LTD.
0.58%
 721,500 0.58% 13,946,602 $

Company contact information

Hisamitsu Pharmaceutical Co., Inc.

408 Tashiro Daikan-machi

841-0017, Tosu

+81 3 5293 1720

http://www.hisamitsu.co.jp
address Hisamitsu Pharmaceutical Co., Inc.(4530)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Hisamitsu Pharmaceutical Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3,748 JPY
Average target price
3,950 JPY
Spread / Average Target
+5.39%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
HISAMITSU PHARMACEUTICAL CO., INC. Stock Hisamitsu Pharmaceutical Co., Inc.
-13.94% 1.83B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+24.17% 562B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.41% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.27% 322B
ABBVIE INC. Stock AbbVie Inc.
+7.61% 297B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.45% 219B
NOVARTIS AG Stock Novartis AG
+6.04% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-10.51% 196B
PFIZER, INC. Stock Pfizer, Inc.
-11.36% 149B
AMGEN INC. Stock Amgen Inc.
-6.82% 146B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4530 Stock
  4. Company Hisamitsu Pharmaceutical Co., Inc.